Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP523799.RAAKZKXZ-HB905g5wjBZsUS-uUa9H9pQJxpWXPO-jiaWw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP523799.RAAKZKXZ-HB905g5wjBZsUS-uUa9H9pQJxpWXPO-jiaWw130_assertion type Assertion NP523799.RAAKZKXZ-HB905g5wjBZsUS-uUa9H9pQJxpWXPO-jiaWw130_head.
- NP523799.RAAKZKXZ-HB905g5wjBZsUS-uUa9H9pQJxpWXPO-jiaWw130_assertion description "[Blockade of VEGFR2 signaling using DC101 anti-VEGFR2 monoclonal antibody enhanced doxorubicin chemoresponse; this combined biochemotherapy inhibited tumor growth and decreased pulmonary metastases without overt toxicity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523799.RAAKZKXZ-HB905g5wjBZsUS-uUa9H9pQJxpWXPO-jiaWw130_provenance.
- NP523799.RAAKZKXZ-HB905g5wjBZsUS-uUa9H9pQJxpWXPO-jiaWw130_assertion evidence source_evidence_literature NP523799.RAAKZKXZ-HB905g5wjBZsUS-uUa9H9pQJxpWXPO-jiaWw130_provenance.
- NP523799.RAAKZKXZ-HB905g5wjBZsUS-uUa9H9pQJxpWXPO-jiaWw130_assertion SIO_000772 16951193 NP523799.RAAKZKXZ-HB905g5wjBZsUS-uUa9H9pQJxpWXPO-jiaWw130_provenance.
- NP523799.RAAKZKXZ-HB905g5wjBZsUS-uUa9H9pQJxpWXPO-jiaWw130_assertion wasDerivedFrom befree-20150227 NP523799.RAAKZKXZ-HB905g5wjBZsUS-uUa9H9pQJxpWXPO-jiaWw130_provenance.
- NP523799.RAAKZKXZ-HB905g5wjBZsUS-uUa9H9pQJxpWXPO-jiaWw130_assertion wasGeneratedBy ECO_0000203 NP523799.RAAKZKXZ-HB905g5wjBZsUS-uUa9H9pQJxpWXPO-jiaWw130_provenance.